On November 6, 2012, VIVUS, Inc. conducted a conference call during which members of its senior management team discussed financial results for the third quarter and nine months ended September 30, 2012 and certain other information. They also reported on the commercial launch of Qsymia™, the regulatory process, the status of partnering efforts for STENDRA™ and business highlights and responded to questions. A copy of the transcript of the conference call is attached hereto as Exhibit 99.1.

The information in this Form 8-K and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, or incorporated by reference into any of the Registrant's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

(d) Exhibits.

Exhibit No.                               Description

99.1          Transcript of VIVUS, Inc. Third Quarter 2012 Earnings Conference
              Call on November 6, 2012, 8:45 a.m. ET.